AI Can Ease Cardiology Workflows, But Patient Trust Gap Remains, Report Finds
New global findings show cardiac care professionals are optimistic about AI's potential to save time and improve diagnoses, while patients remain cautious.
New global findings show cardiac care professionals are optimistic about AI's potential to save time and improve diagnoses, while patients remain cautious.
AI has the power to cut care delays and manage data overload, but trust gaps among clinicians and patients threaten to slow adoption and impact, the report finds.
Philips’ cardiac telemetry Monitoring Service Application did not route some ECG events from July 2022 to July 2024 for cardiology review.
New global findings show cardiac care professionals are optimistic about AI's potential to save time and improve diagnoses, while patients remain cautious.
A consent decree of permanent injunction was issued against Philips Respironics, halting production of their sleep therapy devices.
Read MorePhilips has recalled its BrightView SPECT imaging systems for a potential component failure that would cause parts to fall on the patient.
Read MorePhilips announced that it would stop selling CPAP or BiPAP sleep therapy devices and other respiratory care devices in the U.S.
Read MorePhilips has nabbed U.S. FDA clearance for its X11-4t Mini 3D TEE transducer, designed to provide highly detailed images of the heart for a wider range of patients, including pediatric and complex cases, improving cardiac care and reducing the need for invasive procedures.
Read MoreThe FDA has issued a safety alert regarding Philips Respironics’ DreamStation 2 CPAP machines due to reports of safety issues, including fire, smoke, burns, and overheating, and is working with the company to address the problem and provide safety recommendations to users.
Read MoreRoyal Philips has introduced interoperability between its Capsule Medical Device Information Platform and Patient Information Center iX (PIC iX), enabling hospitals to access a comprehensive patient overview and streamlining the integration of data from various medical devices into a single platform.
Read MoreRoyal Philips and Masimo announce U.S. FDA clearance allowing the activation of SedLine Brain Function Monitoring, Regional Oximetry (O3), and CO₂ measurements in Philips patient monitors: IntelliVue MX750 and MX850.